Population growth, shrinking arable land and climate change are intensifying pressure on global food systems.Microorganism-based ingredients offer a compelling a...

Antibody–drug conjugates (ADCs) are at the forefront of targeted therapy, combining the precision of monoclonal antibodies with the efficacy of cytotoxic agents,...

Demand for end-to-end, integrated manufacturing capabilities continues to amplify in the biopharmaceuticalindustry amid lingering operational and regulatory chal...

The Shift Towards an Integrated Supply ModelThe biopharmaceutical sector is entering a new phase shaped by the clinical and commercial momentumof nucleic acid th...

Modern medicine is predicated on the safety provided by sterility assurance and aseptic practices. The United States Pharmacopeia defines these two important con...

A Turning Point for Drug Development Models The biopharmaceutical industry is at an inflexion point. For decades, animal models have served as the backbone of...